Open house drug discount agreements multienzyme (Lipase, Protease etc.), ATC A09AA02
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Multienzyme (Lipase, Protease etc.), ATC A09AA02
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
25 / 100
Risk factors
No guaranteed sales; actual revenue depends on prescription volumes and market penetration.
Monthly cut-off deadlines require careful timing; missing the 3rd may delay contract start by up to two months.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Mar 2028
- Non-exclusive drug discount agreements for multienzyme products (ATC A09AA02) with AOK Bayern.
- Open-house model: all eligible pharmaceutical companies may join on identical terms.
Show full summary
Open-house model for non-exclusive drug discount agreements (Rabattverträge) for multienzymes (Lipase, Protease etc.), ATC A09AA02, with AOK Bayern. The procedure is not a competitive tender but a continuous open-house where any eligible pharmaceutical company can enter identical, non-negotiable agreements. The contract term is from 1 April 2026 to 31 March 2028, with possible early termination if superseded by regular discount contracts. There is no estimated value, and no award criteria since all eligible participants are accepted. The key eligibility requirement is a signed declaration of reliability. Submissions can be in paper (two copies) or electronically with a qualified electronic signature.
Risks
No guaranteed sales; actual revenue depends on prescription volumes and market penetration.
Monthly cut-off deadlines require careful timing; missing the 3rd may delay contract start by up to two months.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible to participate.
Administrative
- Signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.
- Contract and annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be signed and submitted in duplicate (paper) or with qualified electronic signature.
Requirements may be incomplete.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house drug discount agreements multienzyme (Lipase, Protease etc.), ATC A09AA02
Non-exclusive discount agreements for pharmaceutical products containing multienzymes (Lipase, Protease etc.), ATC A09AA02. The agreement is open to all pharmaceutical companies meeting the eligibility criteria. Contracts start on the first of the month following complete submission, with a monthly cut-off on the 3rd. The latest joining date is 3 February 2028.
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Multienzyme (Lipase, Protease etc.), ATC A09AA02
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich! BITTE BEACHTEN SIE: Die FRIST für einen Vertragsschluss zum nächsten Monatsersten endet jeweils am DRITTEN des Vormonats.
Procurement Details
- Publication date
- 15 Feb 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 107164-2026
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
25 / 100
Risk factors
No guaranteed sales; actual revenue depends on prescription volumes and market penetration.
Monthly cut-off deadlines require careful timing; missing the 3rd may delay contract start by up to two months.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications